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Abstract 
Caspases are a conserved family of cysteine proteases that play important roles in apoptosis and 
innate immunity as well as other cellular processes. Eleven caspase genes have been annotated in 
the mosquito Aedes aegypti. Amongst these, previous studies have demonstrated functional roles 
for AeDronc, CASPS7 and CASPS8 in the Ae. aegypti apoptosis pathway, while CASPS18 and 
CASPS19 have also been functionally characterized. A previous study from our research group 
showed that AeIAP1 has preferential binding for CASPS7 compared to CASPS8. In this study, it 
was confirmed that AeIAP1 has a higher capacity to inhibit CASPS7 than CASPS8. 
Furthermore, five of the remaining Ae. aegypti caspases, namely CASPS15, CASPS16, 
CASPS17, CASPS20 and CASPS21, were characterized. An attempt was made to classify these 
caspases as initiator or effector caspases, based on factors such as the length of their prodomain, 
sequence similarity to known Drosophila initiator and effector caspases, and their substrate 
specificity.  The functions of these caspases in apoptosis was examined in the Ae. aegypti cell 
line Aag2, by using RNA interference to reduce their expression and test the effect on apoptosis.  
Recombinant CASPS16, 17, 20 and 21 were produced in bacteria and the abilities of these 
recombinant proteins to cleave different caspase substrates were examined. From the resulting 
data, it was concluded that CASPS17 and CASPS21 are likely to be effector caspases since they 
preferred a effector caspase substrate. When considering the prodomain length, CASPS17 has a 
short prodomain, but CASPS21 has a long prodomain, which is normally associated with 
initiator caspases. CASPS20 did not show preference for any specific substrate and has a short 
prodomain. Since it did not have a specific preference of substrate, it is likely to be an effector 
caspase based on prodomain length. CASPS16 showed a slightly higher preference for the 
  
initiator caspase substrate WEHD, and has a long prodomain. Based on these results, CASPS16 
is likely an initiator caspase.  
To examine the potential roles of CASPS15, 16, 17, 20 and 21 in apoptosis, their expression in 
Aag2 cells was knocked down using RNA interference. Successful knockdown was verified by 
qRT-PCR. After silencing specific caspases, the cells were exposed to two different apoptotic 
stimuli, ultraviolet radiation (UV) or the RNA synthesis inhibitor actinomycin D (ActD). 
Following apoptotic treatment, apoptosis was measured by two methods; caspase activity was 
measured using an effector caspase substrate, and phosphatidyl serine exposure on the outer 
leaflet of the plasma membrane, which occurs in apoptotic cells, was measured by Annexin V 
staining and flow cytometry.  In cells where CASPS15, 16, 17, 20 or 21 had been knocked down 
and the cells were then treated with UV or ActD, it was observed that effector caspase activity 
and Annexin V staining were both significantly lower than in UV- or ActD-treated cells that had 
received control double-stranded RNA. Together these results suggest that all of these caspases 
are involved in apoptosis in Aag2 cells.  This study serves as a starting point for further research 
on Ae. aegypti caspases and their roles in specific cellular processes. 
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Chapter 1 - Introduction 
 Apoptosis: 
Apoptosis is a regulated programmed cell death mechanism by which cells that are deleterious to 
the organism or are no longer needed are removed (Kerr et al., 1972). Multicellular organisms 
produce cells in excess that do not play any role in the body. Some of the cells produced get 
damaged during production while others are not involved in any specific function in the adult 
organism. In humans, billions of cells need to die every day in order for tissues and organs to 
maintain normal functioning and size (Raff, 1998).  Thus, apoptosis is an important mechanism 
to get rid of unwanted cells for the normal functioning of the body. The regulation of apoptosis is 
as important as other processes like cell division and cell migration (Hengartner, 2000).  
Apoptosis is also required during embryonic development. During embryogenesis, apoptosis is 
involved in processes such as development of lumina of tubular structures, formation of digits in 
the limbs and involution of vestigial organs. Apoptosis is also a natural phenomenon responsible 
for tumor regression. On the other hand, excess apoptosis can cause developmental defects like 
congenital malformations, whereas insufficient amount of apoptosis is seen in tumor formation 
during cancer (Kerr et al., 1972). There are certain diseases that alter the rate of apoptosis 
occurring in the organism. For example, when cells are infected with viruses, they will often try 
to kill themselves using apoptosis. In neurodegenerative diseases like Alzheimers, neurons are 
known to kill themselves by the mechanism of apoptosis. Apoptosis is also activated in the cases 
of organ transplant, insulin-dependent diabetes and AIDS (Ulukaya et al., 2011). 
While undergoing apoptosis there are distinct morphological changes that occur in the cell. 
Firstly, the cells start to shrink and chromatin is cleaved into oligonucleosomal fragments 
following the condensation of chromatin. The plasma membrane undergoes blebbing and 
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spherical pockets of cellular contents called apoptotic bodies are formed. The apoptotic bodies 
thus formed are phagocytized by surrounding cells (Shi et al., 2004). Unlike in apoptosis, when a 
cell is undergoing necrosis it increases in size and the membranes break open, releasing the 
cellular contents to the surrounding cells which activates the inflammatory response (Raff et al., 
1998).  
Apoptosis can broadly be characterized into two separate stages. At the first stage the cell 
commits to undergo cell death and in the second stage distinct morphological changes occur in 
the cell to execute the cell death process (Takahashi et al., 1996). When a cell is undergoing 
apoptosis, homeostasis needs to be disrupted and repair mechanisms in the cells need to be 
turned off. The cell also needs to arrest itself in the same cell cycle state and apoptotic inhibitors 
need to be inactivated. After these changes occur, the cell loses its structural integrity and begins 
to undergo morphological changes. The apoptotic bodies thus formed will have specific signals 
for their disposal (Nicholson et al., 1999). Therefore, the process of apoptosis is a highly 
regulated biological process with very stringent requirements for its activation and execution. 
There are many discriminating characteristics that differentiate apoptosis from other forms of 
cell death like necrosis. In the case of necrosis, the cell membrane is damaged whereas in 
apoptosis the cell membrane initially remains intact with blebbing, and the membrane eventually 
becomes damaged in later stages. In terms of the cell structure, in necrosis the cell swells and 
lyses whereas in the case of apoptosis the cell actually shrinks and apoptotic bodies are formed. 
When a cell undergoes necrosis, lysosomal enzymes are released thus triggering inflammatory 
reaction in the body whereas inflammation does not occur following apoptosis (Ulukaya et al., 
2011). 
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There are certain proteins that are required for the execution of apoptosis. Some of these proteins 
are responsible to activate or increase while others are required to stop or decrease the rate of 
apoptosis in the cells. There needs to be a proper balance of the various regulators in the cell so 
that the normal rate of apoptosis is maintained. Some of the major regulators of apoptosis are 
explained in detail below. 
 Caspases 
Caspases are cysteinyl aspartate-specific proteases that cleave substrates specifically at aspartic 
acid (Asp) residues. High specificity for Asp in the P1 position of the substrate is the major 
distinguishing characteristic of caspases. Although most caspases cleave at the Asp in the P1 
position, the Drosophila initiator caspase Dronc has the capacity to cleave substrates after a 
Glutamate (Glu) at P1 position, including when it autoactivates and when it cleaves Drosophila 
inhibitor of apoptosis protein 1 (DIAP1) (Hawkins et al., 2000). The catalytic site of most 
caspases includes a 5 amino acid motif QACXG (where X is R, Q or G). Contrary to most 
caspases, Dronc has PFCRG motif in its active site. Caspases are synthesized as inactive 
zymogens. The zymogens contain a prodomain followed by large (p20) and small (p10) subunits. 
During activation, a series of cleavages separate the large subunit from the small subunit and the 
prodomain is removed. Active caspases consist of a heterotetramer made up of two small and 
two large subunits. When a cell receives an apoptotic signal, caspases are among the first group 
of proteins to be activated and these in turn cleave cellular substrates like lamins and poly (ADP-
ribose) polymerase, causing morphological changes in the cell that are hallmarks of apoptosis 
(Cohen, 1997). 
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The first evidence indicating that caspases are important in apoptosis came from studies done in 
the nematode Caenorhabditis elegans, where it was found that the protein product of the gene 
ced-3, which was required for apoptosis, was homologous to the mammalian cysteine protease 
interleukin-1β- converting enzyme (ICE) (Thorberry et al., 1992). It was further observed that 
over-expression of ICE (later renamed caspase-1) in mammalian cells caused apoptosis (Miura et 
al., 1993). Since the discovery of the importance of caspases in apoptosis there have been many 
other discoveries showing the role of apoptosis in neuronal cell death and other mammalian cells 
(Gagliardini et al., 1994; Nicholson et al., 1995). Along with the discovery of caspases in 
mammals and C. elegans, one of the other early discoveries of caspases was Sf caspase-1, which 
was cloned from an insect, the fall armyworm (Spodoptera frugiperda) in 1997 (Ahmad et al., 
1997). Caspase homologs have now been identified in numerous organisms including C. elegans, 
Drosophila and mammals, indicating that the apoptotic pathway is evolutionary conserved 
among organisms.  
 Inhibitors of Apoptosis (IAPs) 
Inhibitors of Apoptosis (IAPs) are one of the main regulators that are responsible for inhibiting 
apoptosis. IAPs were originally discovered in baculoviruses (Crook et al., 1993). Soon after their 
discovery in baculoviruses, a homolog of baculovirus IAPs was found in Drosophila, DIAP1. 
DIAP1 was discovered while conducting a genetic screen for mutations that improved the effect 
of endogenous IAP-antagonist Reaper in Drosophila developing eyes (Hay et al., 1995). Along 
with DIAP1, the other IAPs present in Drosophila include Drosophila IAP2 (DIAP2), DETERIN 
and Drosophila BIR repeat-containing ubiquitin-conjugating (dBRUCE) (Orme et al., 2009). 
Neuronal apoptosis inhibitory protein (NAIP) was the first characterized IAP in mammals and 
was discovered while searching for the gene responsible for muscular atrophy (Roy et al., 1995). 
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Along with NAIP, other IAPs in  mammals include XIAP, cIAP1 and cIAP2, which are the IAPs 
known to inhibit caspases-3, -7, and -9 respectively (Deveraux & Reed, 1999; Deveraux et al., 
1998; Deveraux et al., 1997; Roy et al., 1997). In Drosophila, the major IAP protein that is 
responsible for regulating apoptosis is DIAP1 (also known as Thread) (Hay et al., 1995). 
IAP proteins contain one or more Baculovirus IAP Repeat (BIR) domains, a domain which is 70-
80 amino acids long. The BIR domains are crucial in the anti-apoptotic activity of IAPs. The 
structure of BIR domains consists of a three- - -helices 
with three conserved cysteines and one histidine chelating a zinc atom. The BIR domains of 
IAPs directly interact with other binding partners like IAP antagonists and caspases to regulate 
apoptosis (Franklin et al., 2003; Hinds et al., 1999; Sun et al., 1999, 2000). Most IAP proteins 
also contain a Really Interesting New Gene (RING) domain near their carboxy-terminal end 
(Vaux and Silke, 2005). The RING domain has ubiquitin E3 ligase activity and promotes 
autoubiquitylation as well as transubiquitylation of proteins that bind to the RING domains 
(Vaux and Silke, 2005; Vucic et al., 2011). Some IAPs like mammalian c-IAP1 and c-IAP2 also 
possess a caspase recruitment domain (CARD). The CARD domain is present in some caspases 
as well. Like the other domains in IAPs, the CARD domain is also involved in binding of IAP 
with its regulators (Hofmann et al., 1997). 
In baculoviruses, it was shown that IAPs prevent apoptosis caused by viruses (Clem, 2001). The 
mammalian XIAP protein was shown to inhibit activation of the inflammasome and thus 
activation of caspase-1 (Vince et al., 2012). XIAP is also able to inhibit both initiator (caspase-9) 
and effector (caspase-3 and caspase-7) caspases activated during the intrinsic apoptotic pathway 
in mammals (Bratton et al., 2002;  Bratton et al., 2001;  Srinivasula et al., 2001). Drosophila 
DIAP1 is known to inhibit apoptosis by the process of ubiquitylation and proteasomal 
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degradation of caspases and the IAP-antagonistic proteins Reaper, Hid, and Grim (Holley et al., 
2002; Wilson et al., 2002). 
 Along with their roles in apoptosis, IAPs are known to play roles in various human diseases 
especially cancer. There is increased expression of IAPs in various tumor types (Fulda and 
Vucic, 2012; Hunter, et al., 2007; LaCasse et al., 1998). IAPs are important regulators of survival 
signaling pathways (Silke and Brink, 2010). Recently, IAPs have been used as targets for various 
therapeutic processes for diseases like cancer (Silke and Vucic, 2014). 
 IAP Antagonists  
IAP antagonists are proteins that act on IAPs to inhibit their activity. Thus, these proteins are 
pro-apoptotic and their elevated levels correspond to occurrence of apoptosis. IAP antagonists 
are unique proteins because unlike other regulators of apoptosis like IAPs and caspases, these do 
not share high levels of sequence similarity among IAP antagonists of the same organism or even 
between different organisms. The only similarity among IAP antagonists is a conserved N-
terminal motif called the IAP binding motif (IBM). This motif allows the binding of IAP 
antagonists to the BIR domains that are present in IAPs. In Drosophila, it has been observed that 
IAP antagonists, when overexpressed, compete with caspases for binding sites in DIAP1 and 
thus cause apoptosis (Zachariou et al., 2003). Another mechanism of induction of apoptosis in 
Drosophila by IAP antagonists is by the stimulation of DIAP1 by auto-ubiquitylation. Some IAP 
antagonists including Reaper also globally inhibit protein translation to cause apoptosis (Wilson 
et al., 2002; Ryoo et al., 2002; Yoo et al., 2002; Colon-Ramos et al., 2006). 
 IAP antagonists present in Drosophila are Reaper, Hid, Grim and Sickle. These four proteins 
have different affinity towards binding to the BIR domains in DIAP1. Reaper and Grim show 
equal preference for binding to the BIR1 and BIR2 domains, whereas Hid and Sickle have higher 
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affinity for BIR2 than BIR1. In the mosquito Aedes aegypti, two IAP antagonists, Michelob_x 
(Mx) and IMP have been discovered. As in the case of other IAP antagonists, the most obvious 
homology between these two proteins is the IBM sequence (Zhou et al., 2005).  
There are several IAP antagonists in humans and among these, SMAC (second mitochondria-
derived activator of caspases) also known as DIABLO (direct IAP-binding protein with low pI) 
is the most characterized (Du et al., 2000; Verhagen et al., 2000). Smac forms dimers and 
interacts with the BIR domains of XIAP (Wu et al., 2000). Human High temperature requirement 
protein A2 (HtrA2/Omi) and ARTS are other IAP antagonists in humans (Hegde et al., 2002; 
Gottfried et al., 2004). XIAP-associated factor 1 (XAF1) is an endogenous inhibitor of 
XIAP (Varkey et al., 1999). An IAP antagonist named Ibm1 has also been discovered in the 
genome of the silkworm Bombyx mori. Ibm1 was first lepidopteran reaper/grim ortholog 
discovered, and contains an IBM motif. Ibm1 is also known to bind with the BmIAP1 protein in 
Bombyx mori and induce apoptosis in insect cells (Bryant et al., 2009). 
 Defense Repressor 1 (Dnr1) 
Along with the other regulators of apoptosis, Dnr1 has also been shown to be involved in 
apoptosis. It has been identified as an inhibitor of Dredd activity in Drosophila S2 cells (Foley 
and O’Farrell, 2004). Along with its role in controlling apoptosis, Dnr1 has also been shown to 
be involved in the innate immunity in Drosophila (Foley et al., 2009).  
Studies from our laboratory have shown that AeDnr1 plays a role in apoptosis in Ae. aegypti. It 
was observed that silencing of AeDnr1 in Aag2 cells caused spontaneous apoptosis.  Using 
RNAi epistasis experiments, it was determined that AeDnr1 requires the initiator caspase Dronc 
and the effector caspase CASPS8 to induce apoptosis. Among the IAP antagonists it was 
determined that AeDnr1 requires Mx but not IMP (Devore, 2007).   
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 Caspase functions 
Along with the major role that caspases play in apoptosis, there are other several biological 
processes that involve specific roles of caspases. Caspases have been shown to play role in non-
apoptotic cell death pathways like necroptosis, pyroptosis and autophagy.  
Necroptosis is a programmed type of necrosis, the process of cell death in which the dying cell 
and its organelles swell, eventually rupturing the plasma membrane and releasing all the cellular 
contents (Vanlangenakker et al., 2011). 
Pyroptosis is a specific cell death pathway that is known to be involved in the removal of 
macrophages infected with microbes and intracellular pathogens. This process is activated when 
there is acute bacterial or viral infection or an abundance of bacterial toxins.  Human caspase-1 
and caspase-11 are known to be involved in pyroptosis (Miao et al., 2011). Autophagy is a cell 
death mechanism in which the cellular contents are degraded in the lysosomes. Human caspase-6 
and 8 are known to play a role in autophagy (Norman et al., 2010). Drosophila effector caspase 
Dcp-1 has also been shown to be involved in autophagy (DeVorkin and Gorski, 2014). Along 
with the above mentioned cell death mechanisms, caspases have been known to be involved in 
mitotic catastrophe. Mitotic catastrophe occurs when the cells die during mitosis due to buildup 
of DNA damage due to irregularities during the process of cell cycle progression. Caspase 
activation, specifically caspase-2, is known to be involved in the regulation of this process along 
with other proteins like cyclin-dependent kinases (Castedo et al., 2004). 
Along with their roles in the various apoptotic and non-apoptotic cell death mechanisms, 
caspases have been known to play roles in inflammation and immunity. Mammalian caspase-1 is 
known to play a role in processing and maturation of the interleukins IL-1β and IL-18 (Ghayur et 
al., 1997). The Drosophila caspase Dredd is involved in the immune deficiency (IMD) pathway 
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of the innate immune response, which is involved in the immune response against gram negative 
bacterial infection in Drosophila. The caspase Dredd specifically cleaves the NF-kB-related 
protein Relish following exposure to gram negative bacteria, thus activating the IMD pathway 
(Stoven et al., 2003). 
Mammalian caspases have been found to play a role in the differentiation of many cell types. 
Caspase-3 has been found to be involved in the differentiation of lens cells in the eye (Ishizaki et 
al., 1998). Caspases-2, 3 and 9 have been known to play role in differentiation of erythoid cells 
(Zermati et al., 2001). Similar to the roles in mammals, some of the Drosophila caspases have 
also shown to play a role in differentiation and fate determination of various cells. In mutants of 
Drosophila Apaf-1 ortholog (dark), the flies have defects in development and have extra cells. 
This effect is known to be mediated by Dronc (Kurunaga et al., 2006; Kumar S, 2007). 
Caspases have also been shown to play a role in the process of tissue regeneration. In mammals, 
caspase-3 and caspase -7 deficient mice have decreased levels of liver regeneration and wound 
healing (Li et al., 2010). In addition, in invertebrates such as Hydra and in amphibians like 
Xenopus, the process of regeneration is associated with increased level of apoptosis (Chera et al., 
2009; Tseng et al., 2007).  
It has also been shown that caspases are involved in basal lamina remodeling in insects. Matrix 
metalloproteases (MMPs) were able to activate effector caspases which lead to the remodeling of 
the basal lamina in the midgut (Means and Passarelli, 2010). Due to this this remodeling, 
systemic viral infection was established in the insect. The insects used in this study were orally 
infected with baculoviruses and the presence of laminin in the midgut was examined using 
immunohistochemistry using anti-laminin antibody. These insets were infected with and without 
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pan caspase inhibitor zVAD-fmk. It was observed that when caspase activity was blocked using 
inhibitor zVAD-fmk, the disruption of laminin did not occur (Means and Pasarelli, 2010).  
Along with these specific roles, caspases have been known to be involved in tumor formation, 
aging and neural development (Shalini et al., 2014).  All the different roles played by caspases 
show them to be important versatile players in various apoptotic and non-apoptotic processes. 
The study of caspases will thus be important in understanding other biological processes besides 
apoptosis.  
 Caspase Characterization 
Caspases can be classified into two different groups according to their position in the apoptosis 
pathway. The caspases that are first activated by external or internal signals for apoptosis are 
called the “initiator” caspases. Initiator caspases have long prodomains that contain protein-
protein interaction motifs such as the death effector domain (DED) or the caspase activation and 
recruitment domain (CARD) (Fig. 1). These motifs bind to adapter proteins and are involved in 
the autoactivation of initiator caspases, as described further below. The other group of caspases, 
the “effector” caspases, are activated by initiator caspases and cleave the cellular substrates that 
are involved in apoptosis. Effector caspases act downstream of the initiator caspases in the 
apoptosis pathway. Effector caspases have short prodomains lacking discernable motifs 
(Degterev et al., 2003).  
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Figure 1.1. The primary structure of caspases. 
The prodomain, large and small subunits in the proteins are denoted for A) initiator caspases and 
B) effector caspases.  Initiator caspases have long prodomains with binding motifs like CARD or 
DED domains that are responsible for interaction of caspases with adapter proteins, allowing 
autoactivation.  Effector caspases have short prodomains that lack binding motifs. Effector 
caspases require cleavage by other caspases in order to be activated. 
 Caspase activation 
The activation of initiator caspases has been explained using two different models. The first, 
known as the induced proximity model, explains that initiator caspases auto-process themselves 
when brought in close proximity with each other. According to this model, CARD and DED 
domains in caspases interact with comparable motifs in adaptor proteins like Fas-associated 
death domain (FADD), which bring two or more caspase molecules close to each other. When 
the caspases come together, autoactivation occurs (Salvesen and Dixit, 1999). The second model, 
known as the proximity-induced dimerization model, postulates that initiator caspases like 
caspase-8 and -9 dimerize when they come close to each other. The dimerization of these two 
 
A 
B 
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initiator caspases is facilitated by the death-inducing signaling complex (DISC) and the 
apoptosome, respectively (Boatright et al., 2003; Donepudi et al., 2003; Renatus et al., 2001; 
Yan et al., 2005). 
 Caspase Structure 
Much of the structural knowledge of caspase structure comes from studying human caspase-7. A 
functional caspase is a homodimer of heterodimers, consisting of 2 large (~20 kDa each) and 2 
small (~10kDa each) subunits (Fig. 1.2). The active site is formed by five protruding loops, loops 
L1, L2, L3 and L4 from one monomer and loop L2’ from adjacent monomer. This active site is 
highly conserved among all caspases. The substrate binding groove consists of the L1 and L4 
loops. The catalytic Cys that is essential for enzymatic activity is positioned at the end of the L2 
loop. The orientation of the four loops determines the substrate specificity of caspases (Chai et 
al., 2001b; Yan and Shi, 2005).  
During the inactive zymogen state, the loops are in closed confirmation.  Upon activation, all 
loops except L2 move away from their resting state and expose the substrate binding groove 
present in the L1 and L4. In the zymogen state, L2 is also twisted which causes a shift in the 
position of catalytic cysteine away from the active state (Yan and Shi, 2005). 
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Figure 1.2: Active caspases form a heterotetramer. 
Diagrammatic representation of an active caspase. An active caspase consists of a heterotetramer 
made up of 2 large and 2 small subunits. The prodomains are cleaved off during the activation of 
caspases, thus are not included in the active form of the protein. An active caspase contains 2 
active sites.  
Caspases recognize at least four adjacent amino acids in their substrates that are in positions 
named P4-P3-P2-P1. They cleave the substrate after the C-terminal residue in P1 position which 
is usually an Asp residue. Initially, caspases were known to be specific only for Asp at P1 
position, but there is evidence that some caspases, specifically Drosophila Dronc, can also cleave 
after Glu residues (Hawkins et al., 2000; Srinivasula et al., 2001). The binding pockets in the 
caspases are called S4-S3-S2-S1 and these are complimentary to P4-P3-P2-P1 residues in the 
substrate. The conformation at the substrate-binding groove among caspases is highly similar. 
Specifically, the S2 and S4 positions are highly conserved whereas S1 and S3 positions are 
nearly identical among all caspases (Shi, 2002a; 2002b). 
Caspases can also be differentiated according to their preference of substrates. Substrate 
specificity of human caspases was accessed in vitro using peptide substrates coupled to 
aminomethyl-coumarin (AMC). This assay was used to classify human caspases into three 
classes based on their residue preference in the P4 position of the substrate. The first group of 
caspases (Class I) preferred bulky, hydrophobic side chains in the P4 substrate position with the 
optimal sequence of WEHD. The caspases included in this group were caspase -1, -4 and -5. The 
second group of caspases (Class II) preferred intermediate-sized residues in the P4 substrate 
position with sequence similarity to (L/V)EXD. The caspases in this group were caspase -6, -8, -
9 and -11. The third group of caspases (Class III), which includes Caspase -2, -3 and -7, 
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preferred small charged residues in the P4 position of their substrate and the sequence of 
substrate is  DEXD, where X is V, T or H (Thornberry et al., 1997;  Degterev et al., 2003). 
 Caspase regulation 
There are various mechanisms of caspase regulation. Caspases are regulated at the transcriptional  
translational as well as post translational levels (Suzuki et al., 2001b). γ-interferon is known to 
enhance caspase activity in human U937 leukemia cells (Tamura et al., 1996). In mammalian 
apoptosis, the activity and processing of caspases is due to regulation by death receptors and 
cytochrome c.  The activity of caspases has also been known to be altered by posttranslational 
modifications like phosphorylation and dephosphorylation of the active caspases (Earnshaw 
et.al., 1999). Along with the above-mentioned processes, phenomena such as nitrosylation in the 
active sites, oxidation, ubiquitination by IAPs and other proteins have also shown to positively or 
negatively affect caspase activation (Degterev et al., 2003). 
 Apoptosis pathways in different organisms 
 Apoptosis in mammals 
The first caspase, interleukin-1β-converting enzyme (ICE), was identified in humans 
(Thornberry et al., 1992; Cerreti et al., 1992). There have been 14 caspases identified in 
mammals. Among the 14, at least 7 have been known to play a role in apoptosis. Caspase-2, 
caspase-8, caspase-9 and caspase-10 are examples of initiator caspases, while caspase-3, 
caspase-6 and caspase-7 are effector caspases.  
Apoptosis pathways in mammals can be broadly divided into two major categories; extrinsic and 
intrinsic pathways. The extrinsic pathway involves death receptors that are present on the surface 
of cells. This pathway is activated in response to external signals that are received by cells 
convincing the cell to die for the overall well-being of the organism (Degterev et al., 2003). The 
15 
receptors contain intracellular death domains (DD) that recruit adaptor proteins like Fas-
Associated protein with Death Domain (FADD) and Tumor necrosis factor receptor type 1-
associated Death domain protein (TRADD). The adaptor proteins interact with domains of 
molecules involved in apoptosis, like certain initiator caspases, and trigger apoptosis (Yan et al., 
2005).  The intrinsic pathway is the pathway that is activated by intracellular stimuli such as 
DNA damage, cytotoxic drugs or other types of stress (Degterev et al., 2003). Upon receiving an 
intrinsic apoptotic signal, the mitochondria release several molecules like cytochrome c, 
Apoptosis inducing factor (AIF) and others into the cytoplasm of the cell. After reaching the 
cytoplasm, cytochrome c will activate Apoptotic protease activating factor (APAF1) which in 
turn will activate caspase-9 and thus turn on the cascade of caspase activation (Riedl and Shi, 
2004). 
A lot of knowledge on apoptosis and the role of specific caspases has been gained by using 
knockout mice that lack specific caspases. Mice deficient in caspase-8 have abnormal heart 
development and die early during embryonic development (Varfolomeev et al., 1998). Mutant 
mice deficient in caspase-3 and caspase-9 die before birth and exhibit brain malformations that 
occur due to decreased apoptosis in neuroepithelium (Kuida et al., 1996; Zheng et al., 1999;  
Woo et al., 1998; Hakem et al., 1998). Mutant mice with altered caspase-1, caspase -2 or 
caspase-11 do not suffer changes in apoptosis patterns in vivo (Kuida et al., 1995;  Li et al., 1995; 
Bergeron et al., 1998; Wang et al., 1998).  
Apoptosis in the nematode Caenorhabditis elegans 
Cell-death abonormality-3 (CED-3) is the only apoptotic caspase in C. elegans and thus 
functions as both an initiator and effector caspase. There are four genes that act sequentially 
during apoptosis in C. elegans (Horvitz, 2003). Adaptor protein CED-4, which is homologous to 
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mammalian protein Apaf-1, activates CED-3 through oligomerization.  When the cell is not 
undergoing apoptosis, the anti-apoptotic protein CED-9, which is homologous to Bcl-2 protein in 
mammals, suppresses CED-4 activity by direct physical interaction. When a cell receives an 
apoptotic signal, another protein, EGL-1, removes the negative regulation of CED-9 on CED-4, 
thus CED-4 activates CED-3 and the cell undergoes apoptosis. The process of apoptosis is highly 
regulated by these four proteins and it had been documented that 131 cells die due to apoptosis in 
C. elegans in specific locations during distinct developmental stages (Horvitz, 2003; Shi, 2004a, 
2004b). Mutant C. elegans lacking CED-3 do not lose the cells that normally die due to apoptosis 
during development, but nevertheless they seem to develop normally.  
 
Figure 1.3: Summary of apoptosis in C. elegans. 
The regulators of apoptosis act in a cascade, and in the above figure the arrow represents 
activation whereas blunt arrows represent inhibition. In C. elegans, CED-3 is a caspase which 
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acts as both an initiator and effector caspase. CED-3 is regulated by adaptor protein CED-4. 
CED-9 is an antiapoptotic protein in C. elegans which is negatively regulated by another protein, 
EGL-1.  
 Apoptosis in Drosophila melanogaster 
There are 7 caspases in Drosophila. Dronc, Dredd and Strica are initiator caspases and Drice, 
Decay, Damm and Dcp1 are effector caspases. Drosophila Apaf-1 (Kanuka et al., 1999) or Dark 
(Rodriguez et al., 1999) is a protein with homology to mammalian Apaf-1 that is important in 
activating the initator caspase Dronc. When activated, Dronc in turn cleaves and activates 
initiator caspase Drice. During apoptosis, DIAP1 is inactivated by one or more of the four IAP 
antagonist proteins Reaper, Hid, Grim and Sickle through direct physical interaction. This 
activates Dronc, which activates Drice which in turn targets the cellular substrates for apoptosis 
(Shi, 2004). 
 
Figure 1.4: Summary of the apoptosis pathway in Drosophila. 
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 Regulators of apoptosis in Drosophila. The caspases Dronc and Drice are normally inhibited by 
DIAP1. Rpr, Hid and Grim are IAP antagonists that regulate DIAP1. During apoptosis, 
inhibition by DIAP1 of Dronc is lost and Dronc activates Drice, causing apoptosis.  
 Apoptosis in Aedes aegypti 
The apoptosis pathway in Ae. aegypti has not been studied to the same extent as in Drosophila. 
The proteins involved in apoptosis, including caspases and IAPs, were initially annotated during 
searches for immune-related genes using phylogenetic analysis in the malaria vector Anopheles 
gambiae, Drosophila melanogaster and in the dengue vector Ae. aegypti (Waterhouse et al., 
2007). Apoptosis-related genes in Ae. aegypti were further annotated using their homology to 
known apoptosis-related genes in Drosophila (Bryant et al., 2008). This study led to the 
discovery of four additional apoptosis-related genes in Ae. aegypti. Currently, there are 11 
caspases, three IAPs, one Dnr1, and two IAP antagonist homologs annotated in Ae. aegypti. Of 
the 11 Ae. aegypti caspases, only a minority have been characterized to date. AeDronc and 
AeDredd are characterized as initiator caspases whereas CASPS7 and CASPS8 are characterized 
as effector caspases. Further studies are required for the characterization of the other Ae. aegypti 
caspases as initiator or effector caspases.  
Differential expression of certain caspases, namely CASPS16, Aedronc and Aedredd, was 
observed in a refractory strain of Ae. aegypti (Cali-MIB) when compared to the susceptible 
(Cali-S) strain in the presence of dengue virus (Ocampo et al., 2013). This suggests a potential 
role of these caspases in innate immune response against viral infections in Ae. aegypti.  
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Figure 1.5: Summary of apoptosis pathway in Ae. aegypti. 
 In Ae. aegypti, AeDronc is the initiator caspase that activates effector caspases CASPS7 and 
CASPS8. AeIAP1 inhibits AeDronc and AeIAP1 is inhibited by IAP antagonists MX and IMP. 
During apoptosis, the inhibition of AeIAP1 in AeDronc is lost and AeDronc gets activated with 
the help of adaptor protein Ark. When activated, AeDronc in turn activates effector caspases 
CASPS7 and CASPS8, thus turning on apoptosis.  
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Table 1.1: Regulators of apoptosis in Drosophila and Ae. aegypti 
 
Proteins Drosophila Ae. aegypti 
Caspases Dredd, Dronc, Drice, Dcp-1, 
Strica, Damm, Decay 
AeDronc, AeDredd, CASPS7, 
CASPS8, CASPS15, 
CASPS16, CASPS17, 
CASPS18, CASPS19, 
CASPS20, CASPS21 
IAPs DIAP1, DIAP2, DETERIN, 
dBRUCE 
AeIAP1, AeIAP2, AeIAP5 
IAP antagonists Rpr, Hid, Grim MX, IMP 
Other proteins Ark Ark, Dnr1 
 
The various regulators of apoptosis in Drosophila and Ae. aegypti are listed above. Drosophila 
has 7 caspases whereas Ae. aegypti has 11 known caspases. Drosophila has 4 IAPs and Ae. 
aegypti has 3. The high conservation of the apoptosis pathway in these two organisms is depicted 
by the common regulators in these two species.  
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Chapter 2 - Characterization of caspases in the apoptotic pathway 
of Aedes aegypti 
 ABSTRACT 
Caspases are a conserved family of cysteine proteases that play important roles in apoptosis and 
innate immunity as well as other cellular processes. Eleven caspase genes have been annotated in 
the mosquito Aedes aegypti.  A previous study involving two Ae. aegypti effector caspases, 
CASPS7 and CASPS8, found that AeIAP1 has preferential binding for CASPS7 compared to 
CASPS8. In this study, it was confirmed that AeIAP1 has a stronger ability to inhibit CASPS7 
compared to CASPS8. Furthermore, five previously unstudied Ae. aegypti caspases, namely 
CASPS15, CASPS16, CASPS17, CASPS20 and CASPS21, were characterized. An attempt was 
made to classify these caspases as initiator or effector caspases, based on factors such as the 
length of their prodomain, sequence similarity to known Drosophila initiator and effector 
caspases, and their substrate specificity.  The functions of these caspases in apoptosis were also 
examined in the Ae. aegypti cell line Aag2 by using RNA interference to reduce their expression 
and testing the effect on apoptosis. Substrate specificity assays using recombinant versions of the 
caspase proteins CASPS16, 17, 20 and 21 indicated that CASPS17 and 21 are likely to be 
effector caspases since they preferred DEVD, a known effector caspase substrate, even though 
CASPS 21 has long prodomain, which is normally associated with initiator caspases. CASPS20 
did not show preference for any specific substrate but also has a short prodomain, and so was 
also predicted to be an effector caspase. CASPS16 showed a slightly higher preference for the 
initiator caspase substrate WEHD, and has a long prodomain, indicating it is likely an initiator 
caspase. After silencing the expression of each caspase in Aag2 cells, apoptosis was measured 
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after UV and actinomycin D (ActD) treatment by two different criteria; caspase activity was 
measured using an effector caspase substrate, and phosphatidyl serine exposure on the outer 
leaflet of the plasma membrane, which occurs in apoptotic cells, was measured by Annexin V 
staining and flow cytometry.  In cells where CASPS15, 16, 17, 20 or 21 expression had been 
knocked down and the cells were then treated with UV or ActD, it was observed that effector 
caspase activity were significantly lower than in UV- or ActD-treated cells that had received a 
control double-stranded RNA. Similarly, using flow cytometry we also observed that the 
percentage of cells stained with Annexin V was significantly lower in cells where CASPS17, 20, 
and 21 have been knocked down compared to control double-stranded RNA. These results 
suggest that all five of these caspases are involved in apoptosis in Aag2 cells.  This study serves 
as a starting point for further research on Ae. aegypti caspases and their roles in apoptosis and 
other cellular processes. 
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 INTRODUCTION 
Apoptosis is a natural phenomenon occurring in metazoans ranging from hydra to mammals. 
Although there is similarity in the regulators and pathway of apoptosis among closely related 
organisms, there are certain mechanisms and players that are specific to each organism. 
Drosophila melanogaster has been used as the basis for studying apoptosis pathway in other 
insects, including mosquitoes, due to the homology of proteins that play roles in the execution of 
apoptosis. As in Drosophila, apoptosis in the mosquito Aedes aegypti also involves caspases, 
IAP proteins, and IAP antagonists (Denton et al., 2013; Lui and Clem, 2011).  
There are seven caspases in Drosophila, among which three are categorized as initiator caspases, 
while the remaining four are effector caspases. The initiator caspases include Dronc, Dredd, and 
Dream, whereas Drice, Dcp-1, Decay, and Damm are classified as effector caspases. Dronc and 
Drice are the most important caspases involved in apoptosis in Drosophila.  Dredd plays a role in 
immune pathways, whereas Dcp-1 plays a supportive role in apoptosis (Hay and Guo, 2006). 
Little is known about the functions of the other Drosophila caspases. Decay is known to have 
weak apoptotic affect in mammalian cells (Dorstyn et al., 1999). Strica is known to induce cell 
death at low levels in specific tissues like eyes, salivary glands and egg chamber while the 
specific role of Damm is unknown (Harvey et al., 2001; Doumanic et al., 2001). 
The eleven caspases annotated in Ae. aegypti are AeDronc, AeDredd, CASPS7, CASPS8, 
CASPS15, CASPS16, CASPS17, CASPS18, CASPS19, CASPS20, and CASPS21.  These 
caspases were annotated using phylogenetic analysis and comparisons with Drosophila caspases. 
The expression patterns of the Ae. aegypti caspase genes were also examined at the transcript 
level in various developmental stages of Ae. aegypti (Bryant et al., 2008).  In addition, six Ae. 
aegypti caspases have been characterized at the functional level. Ae. aegypti initiator caspases 
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AeDronc and AeDredd were studied by examining the conserved domains present in their 
sequences and comparison with domains in known Drosophila and human caspases. These 
caspases were also studied for their preferred substrates during apoptosis using known substrates 
for human caspases. The expression patterns of these two genes was also studied at various 
developmental stages and tissues in Ae. aegypti (Cooper et al., 2007a, 2007b). 
Functional studies have also been performed on the regulators of apoptosis identified in Ae. 
aegypti. It was observed that silencing of the AeIAP1 gene using RNA interference (RNAi) in 
the Ae. aegypti cell line Aag2 caused spontaneous apoptosis (Liu and Clem, 2011). It was also 
observed that silencing Ae. aegypti Ark or AeDronc repressed apoptosis caused by introducing 
apoptotic stimuli. When the effector caspases CASPS7 or CASPS8, which are most closely 
related to Drosophila Drice and Dcp-1, were silenced it was observed that the degree of 
apoptosis repression was less than when AeDronc was silenced. When CASPS7 and CASPS8 
were co-silenced, it did not cause significant change in apoptosis compared to them being 
individually silenced. These findings indicate that AeDronc, AeArk, AeIAP1, CASPS7 and 
CASPS8 play roles in the apoptosis pathway in Ae. aegypti (Liu and Clem, 2011). To study the 
physical interaction of AeIAP1 with caspases, the BIR domains of AeIAP1 were tested for their 
interactions with caspase proteins. It was observed that AeDronc bound more strongly to the 
BIR1 domain than the BIR2 domain. On the other hand, AeDredd only interacted with BIR1. In 
the same study, it was observed that Drosophila Dronc interacted only with BIR2 of DIAP1 and 
not BIR1 (Wang and Clem, 2011).  
Sequence analysis of one of the caspases identified in Ae. aegypti, CASPS18, revealed 
substitutions in the catalytic site including a substitution in the catalytic cysteine. Due to this 
difference at this crucial position, this caspase did not have caspase activity. However, when 
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CASPS18 was co-expressed with the highly similar CASPS19 (or even when the two 
recombinant proteins were incubated together), the caspase activity of CASPS19 was 
significantly increased. It was therefore concluded that CASPS18 is a decoy caspase (Bryant et 
al., 2010).  Interestingly, even though overexpression of CASPS19, with or without CASPS18, 
resulted in high levels of caspase activity in a lepidopteran cell line, it did not cause apoptosis 
suggesting that CASPS18 and CASPS19 do not play a role in apoptosis (Bryant et al., 2010). 
However, the possible roles of CASPS18 and 19 in apoptosis have not been tested in Ae. aegypti 
cells. 
Phylogenetic analysis of the caspases in Drosophila and mosquitoes has shown that all of the 
Drosophila caspases have homologs in Ae. aegypti, but some mosquito caspases have been 
duplicated, and in some cases it is difficult to assign one-to-one orthology.  In addition, one Ae. 
aegypti caspase, CASPS20, appears to be specific to Culicine mosquitoes (Bryant et al., 2010).  
AeDronc and AeDredd are orthologous to the Drosophila initiator caspases Dronc and Dredd, 
respectively. While looking for orthologs for the Drosophila effector caspases Drice and Dcp-1 
in mosquitoes, it was difficult to assign orthology because Drice and Dcp-1 are more closely 
related to each other than to any mosquito caspases. However, CASPS7 and CASPS8 are the 
closest Ae. aegypti relatives to Drice and DCP-1. The caspases CASPS15, CASPS16, CASPS17 
and CASPS21 from Ae. aegypti are most closely related to Dream and Damm, while CASPS18 
and CASPS19 are most homologous to the effector caspase Decay (Bryant et al., 2010). 
Some of the caspases in Drosophila seem to have originated by gene duplication. For example 
Dream and Damm appear to have arose from a gene duplication event, but they differ in the 
length of their prodomains, with Dream having a long prodomain, whereas Damm has a short 
prodomain.  Similar duplication events seem to have occurred in the evolution of mosquitoes as 
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well, but to an even greater degree. During the evolution of Ae. aegypti, gene duplications have 
given rise to CASPS18 and CASPS19, CASPS15 and CASPS16, and CASPS 17 and CASPS21. 
These caspase pairs share high sequence similarity and interestingly, CASPS 15, 16, 17 and 21 
all group phylogenetically with Dream and Damn in Drosophila which are themselves also 
products of gene duplication (Bryant et al., 2008).  
Length of the caspase prodomain is often used as a predictor of whether a caspase functions as 
an initiator or an effector caspase (Degterev et al., 2003). Comparing the lengths of prodomains 
of the caspases in Ae. aegypti, AeDronc, AeDredd, CASPS15, CASPS16, CASPS21 have long 
prodomains (defined as greater than 100 amino acids upstream of a conserved arginine residue in 
the large subunit), whereas CASPS7, CASPS8, CASPS18, CASPS19, CASPS17 and CASPS20 
have short prodomains. Although the length of prodomain and homology to known Drosophila 
caspases have been used to predict whether the Ae. aegypti caspases are initiator or effect 
caspases, these factors do not necessarily always provide enough information to allow this type 
of classification.  
The Ae. aegypti caspases are compared in Table 2.1 in terms of the length of their prodomain, 
their closest Drosophila homolog, and whether they are known to play a functional role in 
apoptosis. CASPS18 and CASPS19 have only been studied by overexpression in lepidopteran 
cells, thus there some uncertainty about their roles in apoptosis. 
Apart from AeDronc, CASPS7, CASPS8, CASPS18 and CASPS19, the functions of the other 
Ae. aegypti caspases that were annotated in 2008 have not been examined. The aim of this study 
was to functionally characterize the other Ae. aegypti caspases, namely CASPS15, CASPS16, 
CASPS17, CASPS20 and CASPS21. For this characterization, we used RNAi and substrate 
preference determination using recombinant proteins as our major approaches. The findings from 
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this study provide valuable insights into whether these specific caspases play a functional role in 
apoptosis in Ae. aegypti and also help to characterize them as initiator or effector caspases.  
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 MATERIALS AND METHODS 
 Cells  
Aag2 cells, which were originally derived from embryonic tissue of Aedes aegypti, were grown 
in Schneider’s medium (Invitrogen) supplemented with 10% fetal bovine serum (FBS) (Atlanta 
Biologicals). For all the RNAi, RNAi epistasis and flow cytometry experiments, the cells were 
plated in Falcon 
TM
 12 well tissue culture plates.  
 Plasmids 
Plasmids containing green florescent protein (GFP), AeDronc, AeCASP7, AeCASP8, 
AeCASP20, and AeCASP21 were produced by cloning the corresponding PCR products into the 
pCRII vector using Dual Promoter TA Cloning Kit (Invitrogen) according to manufacturer’s 
protocol. Plasmids for AeCASP16 and AeCASP17 contain the full length caspase sequences 
cloned into the PET-23a vector, and were produced via gene synthesis by Genscript
TM
.  
 Apoptosis treatment 
Ultraviolet radiation (UV) and actinomycin D (Act D) were used as the apoptotic treatments in 
this study. For UV treatment, the plates were placed on a UV transilluminator for 4 minutes at 
maximum intensity. For Act D treatment, each well was treated with 1μg/ml of Act D. 
 RNAi 
Double-stranded RNAs (dsRNAs) for specific opening reading frames for the genes of interest 
were synthesized using the T7 High Yield Transcription Kit (Epicentre) using the manufacturer’s 
protocol. The protocol was multiplied to produce 200 µl of dsRNA per reaction and these were 
divided into aliquots of 20 µl and stored before use. The dsRNA were stored in aliquots of 20 µl 
in -20
o
C. 
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For specific RNAi experiments, Aag2 cells were plated in 12 well tissue culture plates and 
allowed to attach. When the cells were attached, media (Schneider’s with FBS) was removed and 
washed using Schneider’s media without FBS. 1 ml of media (without FBS) was added to each 
well and 40 µg of the specific dsRNA of interest was added to the specific well. The plate with 
cells was left rocking at room temperature for 4-6 hrs and the cells were then supplemented with 
1 ml of Schneider’s media with 20% FBS. Two sets of cells were plated for each dsRNA in each 
experiment. The first set of cells was harvested 24 hours after dsRNA addition. These cells were 
used for qRT-PCR analysis to confirm the knockdown of the specific genes. After 24 hours, UV 
or Act D were applied to the cells. A second set of cells were harvested 12 hours after exposure 
to apoptotic induction and these cells were used for caspase activity assay. 
 qRT-PCR 
Real time PCR was done on cells harvested 24 hours after dsRNA application. After harvesting, 
total RNA was extracted from the cells using standard Trizol 
TM
 (Invitrogen) protocol. 0.5 μg of 
RNA was used in a reverse transcription reaction to produce the complementary DNA (cDNA) 
for the samples. The reverse transcription reaction was performed using cDNA Synthesis 
with SuperScript® III RT kit (ThermoFisher Sci entific) following the standard 
manufacturer’s protocol using an oligo-dT primer. 20 µl of cDNA was produced from each 
reaction. All the cDNA samples produced were diluted 1:20 and 2 µl of each cDNA was used for 
each qRT-PCR reaction. 2 µl of 10 µM primer (produced by Integrated DNA technologies 
TM
) 
and 7 µl of 2X SYBR Green Mastermix (ThermoFisher Scientific)  were added into the final 
PCR mixture of 15 µl. 
The plates were run in a PCR cycle consisting of step 1: 95°C for 3 min, step 2: 30 cycles of 
95°C for 15 sec followed by 55-60°C for 30 sec, step 3:  95°C for 1 min with the melt curve 
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cycle at the end. For each sample the threshold cycles (Ct) value was recorded. Standard curves 
for the genes were produced by plotting the Ct value obtained for each dilution against the log of 
its concentration. The Ct values for the experimental samples were then plotted onto this dilution 
series standard curve. The relative expression value (REVs) for each gene was produced using 
ribosomal protein S7 as housekeeping gene. t-test was used to determine the significance for 
each data set.    
 Caspase activity assay 
Caspase activity of the cells was measured using substrate N-acetyl-Asp-Glu-Val-Asp - 
7-amino-4-trifluoromethyl-coumarin (Ac-DEVD-AFC). The cells were harvested after the 
apoptotic treatment (UV or ActD) and collected by centrifuging at 5000g for 2 min. The media 
was removed and the cells were washed using PBS. After washing, the cell pellets were 
resuspended in 100 μl lysis buffer (20mM HEPES*KOH, pH 7.5, 50 mM KCl, 1.5 mM MgCl2, 
1 mM EDTA, 1 mM EGTA, 1mM DTT). The cells were lysed by 3 freeze (-80 °C) and thaw 
(room temperature) cycles. For each of the caspase assay, the protein concentration of sample 
was determined using BCA assay. 50 µM of each sample was added to white opaque 96 well 
plates and reaction buffer (100 mM HEPES, pH 7.4, 2 mM DTT, 0.1% CHAPS, and 1% sucrose) 
added to the each reaction making the total volume 100 µl. The samples were incubated at 37
o
C 
for 30 minutes. Caspase substrate Ac-DEVD-AFC (MP Biomedicals)  was added at 
concentration of 20 µM after incubation and fluorometric measurements (excitation 405 nm, 
emission 535 nm) of the samples were performed using a Victor3 1420 Multilabel Counter 
(Perkin Elmer).  
The samples were read every minute for 90 minutes. The change in activity over time 
(∆RFU/time) was calculated by calculating the slope of the activity/time graph over the time 
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period that the slope changed the most. The first 30 minutes of the assay was the time considered 
for this calculation in most cases, as that time frame had the most change in activity. The percent 
change in activity was calculated by setting the caspase activity of the control sample (dsGFP) as 
100 % and converting all the other samples using this term. 
 Active site titration assay 
To determine the amount of active caspase present in a purified preparation, active site titration 
was performed. For this assay purified recombinant caspases were incubated with increasing 
concentrations of the irreversible caspase inhibitor ZVAD-FMK. Reaction buffer (100 mM 
HEPES, pH 7.4, 2 mM DTT, 0.1% CHAPS, and 1% sucrose) was added to each sample bringing 
the total volume of reaction to 100 µl and the reactions were incubated at 37⁰C for 30 min. After 
incubation, 20 µm caspase substrate (Ac-DEVD-AFC) was added to each reaction. The 
fluorescence (excitation 405 nm, emission 535 nm) was measured over time. For each sample, 
the rate or slope (y-axis) was plotted against inhibitor concentration (x axis). The concentration 
of active caspase in each preparation was determined as the x-intercept of the above mentioned 
graph.  
 Caspase inhibition assay using AeIAP1 
Equivalent concentrations of active AeCASPS7 and AeCASP8 (8µM) were incubated with the 
increasing (6 µM – 64 µM) concentrations of AeIAP1 at 37 oC for 30 min. Caspase reaction 
buffer (100 µl) was added to this reaction. After 30 min, 20 µM caspase substrate (Ac-DEVD-
AFC) was added to each sample. Fluorometric analysis (excitation 405nm, emission 535 nm) of 
the samples were performed using Victor3 1420 Multilabel Counter (Perkin Elmer). The change 
in activity (∆RFU/time) for each sample was calculated using above mentioned procedure for 
caspase activity.  
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 Recombinant protein production 
His-tagged AeCASP7, AeCASP15, AeCASP16 AeCASPS20 and AeCASPS21 as well as GST-
tagged AeIAP1 were produced by expression in BL21 strain of E. coli.  The bacteria cultures 
were grown as 50 ml cultures overnight at 37 
o 
C. These overnight cultures were used to start a 1 
liter culture and these were allowed to reach Optical Density (OD) of 0.6 at 37 
o 
C. After the OD 
reached 0.6, the cells were induced for protein production using 0.05 M IPTG and incubated at 
18
o
C overnight. The cell pellets were collected after induction by centrifuging the samples at 
12000g for 20 min each. The cell pellets were collected and resuspended in 40 ml lysis buffer 
(200 mM Tris-Cl pH 8.0, 0.4 M ammonium sulfate, 10 mM MgCl2, 10% glycerol, and protease 
inhibitor cocktail (Roche)) and sonicated for 3 min (15 sec bursts with 10 sec break in between).   
The supernatant was collected after centrifugation (12000g for 5 minutes) of the lysed samples. 
The supernatants were further purified using TALON
TM
 resin for His-tagged proteins and 
glutathione sepharose-conjugated beads for GST tagged protein following the manufacturer’s 
protocol.  The protein concentration of the supernatant and purified proteins was measured using 
BCA assay. Equal concentrations of proteins were used for each caspase activity assay. You 
need to describe how you ended up having to use the unpurified supernatant. 
 RNAi epistasis 
To perform the double knockdown experiments, 20 µg dsRNA corresponding to each of two 
caspases were added, making the total dsRNA in each reaction 40 µg. When single caspases 
were knocked down in each of these experiments, 40 µg of one dsRNA was added per reaction. 
Therefore, the total amount of dsRNA added to each treatment cells remained the same. The 
apoptotic signal UV or Act D was applied 24 hrs after the dsRNA treatment as mentioned in all 
experiments.  
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 Flow cytometry 
Flow cytometry was performed using the PE Annexin V Apoptosis Detection Kit I™ (BD 
Pharmingen) on Aag2 cells using a BD Fortessa X-20 flow cytometer. The kit provided two 
dyes, Annexin V conjugated with PE, which stained the apoptotic cells in a population and 7-
Amino-Actinomycin (7-AAD) which is a nucleic acid-binding dye and only stains cells with 
damaged (permeable) membranes, ie necrotic or late stage apoptotic cells.  
To prepare the samples, Aag2 cells were plated in 12 well plates and allowed to attach. After 
attachment, UV or Act D was applied to the cells. 12 hours after application of apoptotic signal, 
the cells were harvested and washed twice using cold PBS. The cells were then resuspended in 
250 µl of 1X Binding Buffer (provided in the kit). After resuspending in Binding Buffer, 5 µl of 
the specific dye PE Annexin V or 7-AAD were added to the respective samples. For the PE 
Annexin V with 7-AAD sample, 2.5 µl (total 5 µl)  of each dye was also added to treatment cells. 
The samples were then gently vortexed and incubated for 15 min at room temperature (25°C) in 
the dark. After 15 minutes, 250 µl of 1X Binding Buffer again was added to each sample. The 
samples were then transported on ice to be analyzed by flow cytometry.  
 Substrate specificity assay 
The substrates used in this assay were purchased from MP Biomedicals and are represented in 
the Table 2.2.  
Supernatants from lysed bacteria expressing the recombinant proteins CASPS15, 16, 17, 20 or 21 
were incubated with the 50 µM concentration of above-mentioned substrates and caspase activity 
was measured using a Victor plate reader after incubation at 37 
0
C for 30 min. The change in 
activity was measured as described above. 
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 RESULTS 
 Ability of AeIAP1 to inhibit CASPS7 versus CASPS8 
Previous experiments indicated that the caspase inhibitor AeIAP1 is able to bind more strongly 
to CASPS7 compared to CASPS8 (Devore, 2009). To determine if the stronger binding 
correlated with the inhibitory capacity of AeIAP1, we tested the ability of recombinant AeIAP1 
to inhibit the ability of an equivalent concentration of active CASPS7 and CASPS8 to cleave a 
synthetic effector caspase substrate, N-acetyl-Asp-Glu-Val-Asp -7-amino-4-trifluoromethyl-
coumarin (Ac-DEVD-AFC). In order to compare the ability of AeIAP1 to inhibit these effector 
caspases, recombinant CASPS7 and CASPS8 were expressed and purified from bacteria. We 
observed that equal concentrations of recombinant CASPS7 and CASPS8 (as determined by 
BCA assay) had varying levels of caspase activity, with CASPS7 having higher activity than 
CASPS8 (data not shown). When caspases are expressed in bacteria, autoactivation occurs due to 
concentration effects. However, the extent of activation can vary between protein preparations.  
In addition, contaminating proteins can be present at different concentrations, affecting the total 
amount of protein as determined by BCA assay. For our study, it was important to use equal 
concentrations of active CASPS7 and CASPS8 to determine the extent of inhibition of the 
caspases by AeIAP1. The amount of active caspase in each reaction was thus determined by 
performing active site titration using the irreversible caspase inhibitor N-Benzyloxycarbonyl-
Val-Ala-Asp(O-Me) fluoromethyl ketone (ZVAD-FMK). Since the concentration of ZVAD-
FMK added is accurately known, this concentration can be used to determine the amount of 
active caspase in a specific batch of caspase protein. In active site titration, the amount of active 
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caspase in the reaction can be determined by the amount of inhibitor required to bring the 
caspase activity to zero.  
When increasing amounts of ZVAD-FMK were mixed with CASPS7 or CASPS8 protein, the 
same concentration of CASPS7 protein as determined by BCA assay had approximately twice 
the amount of active caspase compared to CASPS8 (Fig. 2.1A and Fig. 2.1B). The concentration 
of active CASPS7 was calculated as 4.49 µM, while that of CASPS8 was 9.34 µM. 
When equal concentrations of active CASPS7 or 8 were incubated with recombinant AeIAP1 
protein, the results indicated that AeIAP1 was able to inhibit both caspases, but that it inhibited 
CASPS7 more efficiently than CASPS8 (Fig. 2.2).  At an 8:1 ratio of AeIAP1:caspase, CASPS7 
was inhibited by 6.4-fold, while CASPS8 was inhibited by only 1.6-fold. This correlates with the 
results from previous studies from our laboratory suggesting that AeIAP1 is likely to inhibit 
apoptosis by inhibiting CASPS7 rather than CASPS8 (Devore, 2009). 
 The roles of several uncharacterized Ae. aegypti caspases in apoptosis  
The roles of CASPS7, CASPS8, and Dronc in apoptosis have been previously examined (Liu and 
Clem, 2011). To determine whether any other caspases play roles in the apoptosis pathway in Ae. 
aegypti, we used RNA interference (RNAi) to knock down the expression of several previously 
uncharacterized Ae. aegypti caspases in Aag2 cells, and studied the effects on apoptosis, 
including caspase activity and cell viability. dsRNAs specific for each caspase were used to 
individually knock down CASPS15, CASPS16, CASPS17, CASPS20 and CASPS21 in Aag2 
cells. The expression of each of the caspases was significantly decreased after treatment by the 
specific dsRNA, as measured by qRT-PCR (Fig. 2.3). dsRNA for green florescent protein 
(dsGFP) was used as a non-specific dsRNA negative control. As an additional control, some of 
the cells were not treated with any dsRNA and represented the normal level of caspase 
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expression in Aag2 cells. The level of significance was determined by using t-test to compare 
dsGFP and dsRNA for the specific caspases. The silencing of a caspase, for example CASPS17 
did not affect the expression of other caspases like CASPS15, CASPS16 and others. However, 
the silencing of CASPS15 decreased the expression of CASPS16 because of their high degree of 
similarity. But the silencing of other caspases like CASPS17, CASPS20, CASPS21 did not affect 
the expression of other caspases even the ones that were closely related. Therefore, the silencing 
of caspases appeared specific except for CASPS15 and 16 (data not shown). 
After demonstrating that the caspases were effectively and specifically knocked down by RNAi, 
dsRNA-treated Aag2 cells were introduced to two different kinds of apoptotic stimuli. 
Ultraviolet radiation (UV) is known to cause apoptosis by damaging cellular DNA, whereas 
actinomycin D (Act D) is an inhibitor of RNA synthesis and is known to cause apoptosis in a 
variety of insect cell lines, due at least in part to inhibition of IAP expression (Miller et al., 
1993). In separate experiments, UV and ActD were used as two different stimuli for apoptosis 
activation in Aag2 cells.  
Aag2 cells were treated with dsRNA for specific caspases and 24 hrs later, the cells were 
exposed to apoptotic stimuli. Caspase activity of the cells, as measured using DEVD-AFC was 
significantly decreased when each of the caspases was silenced, compared to cells treated with 
dsGFP (Fig. 2.4A and B). The level of significance was determined using t-test.  The lower 
caspase activity in the cells treated with caspase dsRNAs indicates that the rate of apoptosis 
occurring in these cells was lower than in the control cells treated with dsGFP. The results 
indicated that the caspase activity was decreased to a similar degree by knocking down each of 
the caspases. This result suggests that these caspases all contribute to apoptosis in Ae. aegypti.  
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After knocking down individual caspases in Aag2cells, we sought to determine whether 
knocking down two caspases at a time had an additive effect. For double knockdowns, we picked 
dsRNA pairs that shared sequence similarity. CASPS15 and CASPS16, as well as CASPS21 and 
CASPS17 were chosen as pairs since these share high sequence similarity. After treatment with 
the combinations of dsRNA, the cells were exposed to UV and caspase activity was measured. 
Surprisingly, we did not observe an additional effect on the decrease in caspase activity when 
two genes were knocked down compared to single genes being knocked down. The caspase 
activity of individually silenced cells were not significantly different than cells with double 
dsRNA treatment. The level of significance was determined using t-test. When CASPS15 and 
CASPS16 were individually knocked down, the change in activity was similar to double 
knockdowns with CASPS15 and CASPS16 together, but this may have been due to the fact that 
silencing of these two genes was not specific.  However, similar results were obtained for 
CASPS17 and 21 (Fig. 2.5A), which were able to be specifically silenced. There was a trend 
towards a slight decrease in caspase activity in the double knockdowns compared to single, but 
the change was not significant. Similar results were observed when Act D was used as the 
apoptotic stimulus for the single and double knockdown treatments (Fig. 2.5B). In summary, 
there was no significant difference when knocking down two caspases compared to single 
knockdowns as determined by t-test. 
For the next set of RNAi epistasis experiments, we wanted to determine whether knocking down 
a known apoptotic initiator caspase, AeDronc, with the other caspases would cause an additional 
impact on caspase activity following an apoptotic stimulus. For this experiment, Aag2 cells were 
treated with dsRNA for each caspase alone, or together with AeDronc. UV and Act D were used 
as apoptotic stimuli again and caspase activity was measured 12 hours post apoptotic treatment. 
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We again observed a slight decrease in caspase activity when knocking down various caspases 
with AeDronc, compared to knocking down the caspases by themselves, but the change was not 
significant as determined by t-test.  This was the case when either UV (Fig. 2.6A) or Act D (Fig. 
2.6B) was used as the apoptotic stimulus.  
 Substrate specificity of uncharacterized Ae. aegypti caspases 
The substrate specificity of caspases is one of the factors that determine their characterization as 
initiator or effector caspases. Since several Ae. aegypti caspases have not been characterized, we 
wanted to get more information about these caspases and their potential roles in apoptosis. We 
thus produced recombinant proteins for CASPS16, CASPS 17, CASPS20 and CASPS21 using 
the E. coli expression system. After induction of caspase expression, the caspases were purified 
using TALON
TM
 resin, and the caspase activity of the cell supernatant, washes and elutions 
collected was measured. Unfortunately, the caspase activity in the unpurified supernatant was 
significantly higher than the washes and elution fractions, suggesting that the purification 
method was not working well for these caspases (Fig. 2.7A-D). 
To circumvent this problem, bacterial supernatants containing unpurified recombinant capsases 
were used in caspase assays. As a negative control for background protease activity, a CASPS7 
construct with a mutation in the active site (Cys2Ala) was expressed and used in caspase assays. 
The substrates used were a commercially available set of caspase substrates consisting of several 
conjugated peptides that have been used to classify human caspases (MP Biomedicals).  
Lysates containing the individual recombinant caspases were mixed with the various substrates 
and activity was measured. As expected, lysate containing mutant CASPS7 protein had very low 
caspase activity, indicating that there is negligible background activity in the bacterial lysate 
(Fig. 2.8A).  CASPS16 did not have a strong preference for any of the substrates tested, however 
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activity with WEHD-AFC was significantly higher compared to others (Fig. 2.8B). CASPS17 
showed preference for the substrates DEVD-AFC, WEHD-AFC, VEID-AFC and LEHD-AFC 
compared to the other substrates (Fig. 2.8C). CASPS20 showed similar caspase activity with all 
the tested substrates, although it had the highest activity with VEID-AFC (Fig. 2.8D). CASPS21 
exhibited preference for DEVD-AFC, WEHD-AFC, VEID-AFC and LEHD-AFC compared to 
the other substrates (Fig. 2.8E). The significance of caspase preference was determined using one 
way Analysis of Variance (ANOVA). Overall, the caspases demonstrated varying preferences 
for the known human caspase substrates.  
Flow cytometry was used as another method to determine the levels of apoptosis when individual 
caspases or pairs of caspases were silenced.  Annexin V and 7-Amino-Actinomycin (7-AAD) 
were used to stain to the cells. Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding 
protein that has a high affinity for the phospholipid phosphatidylserine (PS), and binds to cells 
with exposed PS. Since PS is translocated from the inner leaflet to the outer leaflet of the plasma 
membrane during the early stages of apoptosis, Annexin V staining can be used to measure cells 
undergoing apoptosis (Koopman G, et al 1994). For the flow cytometry analysis, Annexin V 
conjugated with the fluorochrome Phycoerythrin (PE) was used to stain apoptotic cells. 7-AAD 
is a DNA stain that is only taken up by cells that have damaged membranes, thus it stains 
necrotic and late apoptotic cells.  
It was first important to determine whether flow cytometry could be successfully used to 
measure apoptosis in Aag2 cells, as use of this technique in this cell line has not been reported 
previously to our knowledge. Fig. 2.9 depicts the raw data from a representative flow cytometry 
analysis that was performed to optimize the staining procedure. The x-axis represents Annexin 
V-PE staining, whereas the y-axis represents the 7-AAD staining. A higher number of Annexin 
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V-positive cells were observed when the cells were exposed to UV compared to untreated cells 
(Fig. 2.9A and B). Similarly, in cells stained with 7-AAD there were higher number of 7-AAD 
positive cells in the UV-treated sample compared to the untreated (Fig. 2.9C and D).  In cells 
treated with both Annexin V and 7-AAD, there was higher number of Annexin V, 7-AAD as 
well as dual positive cells compared to the untreated group (Fig. 2.9E and F). These results 
suggest that flow cytometry with Annexin V and 7-AAD staining can be used to measure 
apoptotic Aag2 cells.  
The accumulated data from three biological replicates of Aag2 cells stained with Annexin V, 7-
AAD or Annexin V + 7-AAD and either UV-treated or untreated cells are shown in Fig. 2.10. 
For each treatment, the percentage of cells stained with Annexin V, 7-AAD or both stains are 
represented (Fig. 2.10). In the case of both Annexin V- and 7-AAD-stained cells, significantly  
higher percentage of positive cells was observed in UV-treated cells compared to untreated cells 
as determined by t-test. When the cells were stained with both dyes, there was also a higher 
number of dual-positive cells in the UV-treated group compared to untreated cells (Fig. 2.10). 
These results correlate with the results from the caspase activity assay, indicating higher 
apoptosis after UV treatment.   
Flow cytometry was then used to determine the effects of silencing individual caspases cells on 
UV-stimulated apoptosis.  Aag2 cells were treated with the indicated dsRNAs, and 24 hrs later 
the cells were treated with UV.  At 12 hrs after UV treatment, the cells were harvested and 
stained with Annexin V and 7-AAD. It was observed that there was significantly higher 
(determined by t-test) proportion of Annexin V and 7-AAD-stained cells in all the dsRNA 
treatments after UV exposure (Fig. 2.11). Thus, this method can thus be used to compare the 
number of apoptotic cells in cells knocked down with one caspase versus another.  
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While comparing the percentage of Annexin V positive cells between the dsGFP and caspase 
dsRNA  treatment groups using t-test, it was observed CASPS15, CASPS20 and CASPS21 had 
significantly lower number of Annexin positive cells after UV treatment compared to dsGFP 
treated cells. This indicates less number of apoptotic cells are present after UV treatment in the 
caspase dsRNA treated cells compared to dsGFP treated cells. This results confirms with the 
results obtained from measuring caspase activity after silencing of CASPS15, CASPS20 and 
CASPS21 (Fig 2.4A), providing further evidence for the role of these caspases in apoptosis in 
Aag2 cells.   
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 DISCUSSION: 
In this study, we have characterized the substrate specificity of several previously 
uncharacterized Ae. aegypti caspases, and also investigated the roles of these caspases in 
apoptosis using RNAi. The genomes of mosquitoes that have been examined thus far, including 
Ae. aegypti, have an expanded number of caspase homologs compared to other insects whose 
genomes have been sequenced (Bryant et al., 2008). Our results provide an initial assessment of 
the functional relevance of some of these additional caspase homologs. 
We also examined the ability of two previously characterized Ae. aeygpti caspases, CASPS7 and 
CASPS8, to be inhibited by the caspase inhibitor AeIAP1. Our results indicated that CASPS7 
and CASPS8 were both inhibited by AeIAP1, but the inhibition of CASPS7 was stronger than 
that of CASPS8. This suggests that AeIAP1 has a preference for inhibiting CASPS7. Previous 
study of the interaction of AeIAP1 with CASPS7 and CASPS8 was performed using in vitro 
translated AeIAP1 protein and recombinant caspase proteins. Pulldown assay using these 
proteins indicated that AeIAP1 bound more strongly to CASPS7 than CASPS8 (Devore, 2009). 
Therefore, our results agree with the previous protein interaction data, and support the 
conclusion that AeIAP1 acts preferentially on CASPS7 versus CASPS8 in the apoptosis pathway 
of Ae. aegypti.  
To study the substrate preference of the effector caspases CASPS15, CASPS16, CASPS17, 
CASPS20 and CASPS21, we expressed the caspases as recombinant, His-tagged proteins, using 
an E coli expression system. We observed high levels of expression of the caspases in the 
bacterial cell supernatants, indicating that the recombinant proteins were soluble. However, we 
were not able to isolate useable levels of the caspases using the His tag for purification, despite 
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multiple attempts. Potential reasons for the difficulty in purifying the recombinant proteins may 
be either the protein did not bind properly with the TALON resin or it could not successfully be 
eluted from the beads by the elution buffer used. Due to this it was difficult to obtain useable 
concentrations of recombinant caspase protein.  Therefore, we used the supernatant fraction of 
the bacterial cell lysates, which contained the expressed Ae. aegypti caspase proteins, to perform 
the substrate preference assay. The expression of caspases in the supernatants was confirmed 
because the supernatant had significantly higher caspase activity assay compared to supernatant 
obtained after identical expression and treatment of the active site mutant of CASPS7. Since the 
caspases were expressed and were active in the supernatant, we decided to use it for our substrate 
specificity assay. Although using purified recombinant proteins would be preferred, since we 
observed specific caspase activity in the supernatant our approach could be used as well.  A 
similar approach of using supernatants obtained after lysis of E coli cells was used previously to 
determine the substrate preference for AeDredd (Cooper et al., 2007).  
The substrates used in our assay are known substrates for human caspases that have been used to 
classify caspases by their substrate specificity (MP Biomedicals,Inc.).  Although substrates that 
are customized for insect caspases are not available, due to the high structural similarity among 
all caspases, the human caspase substrates are very helpful for basic understanding of the insect 
caspases, and have been widely used to characterize other insect caspases (Lui et al., 2005; 
Degterev et al., 2003).  
Caspases are commonly classified as initiator or effector caspases, mainly based on two criteria: 
1) substrate specificity and 2) the length of their prodomain, as well as the presence of known 
structural domains in the prodomain of initiator caspases that bind to adapter proteins and allow 
their activation. The substrate specificity assay was one of the methods used to determine 
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whether the caspases are initiator or effector caspases. In the case of Drosophila and human 
caspases, it has been observed that certain substrates are preferred by initiator versus effector 
caspases. The preferred substrate for the Drosophila initiator caspase Dronc is VDVAD 
(Hawkins et al., 2000), while the Drosophila effector caspases Drice, Dcp-1 and Decay prefer 
DEVD (Kumar and Doumanis 2000, Dorstyn et al 1999). We attempted to use this knowledge 
obtained by using known human caspase substrates, combined with prodomain length, to 
differentiate among Ae. aegypti caspases.  
From our recombinant protein data, we can tentatively conclude that CASPS17 and CASPS21 
are likely to be effector caspases since they preferred the substrate DEVD compared to VDVAD. 
When comparing the prodomains, CASPS17 has a short prodomain, consistent with its substrate 
preference. CASPS21 has a long prodomain, which seems inconsistent with its preference for 
DEVD. However, when the prodomain of CASPS21 was scanned using PROSITE
©
 there were 
no recognizable interaction motifs found that are normally present in initiator caspase 
prodomains.  Thus, we conclude that CASPS21 is likely to be an effector caspase, despite its 
long prodomain. CASPS20 did not show preference for any specific substrate and also has a 
short prodomain, indicating it is also likely to be an effector caspase. CASPS16 showed slightly 
higher preference for WEHD, and has a long prodomain. Based on this results, it is likely to be 
an initiator caspase.   
Our results indicate that CASPS15, CASPS16, CASPS17, CASPS20 and CASPS21 are 
expressed in Aag2 cells and the expression of these genes can be successfully reduced using 
RNAi. The expression of the transcripts of these caspases in Aag2 cells was previously 
confirmed by RT-PCR (Lui and Clem, 2011). In the same paper it was shown that Aag2 cells can 
uptake dsRNA and be used for RNAi experiments.  The expression pattern of all of the above 
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mentioned caspases was also analyzed in different developmental stages of Ae. aegypti including 
larvae, pupae and adults as well as in midgut tissue in adult females (Bryant, 2008).  
Silencing of the effector caspases CASPS7 or CASPS8, which are the closest relatives to DrICE, 
caused a decrease in apoptosis (Lui and Clem, 2011). When comparing CASPS7 and CASPS8, 
silencing CASPS7 produced a more dramatic effect compared to silencing CASPS8. Co-
silencing both of them decreased caspase activity similar to when only CASPS7 was silenced 
and co-silencing did not completely deplete caspase activity (Lui and Clem, 2010). In our study, 
we observed that silencing of CASPS7, CASPS15, CASPS16, CASPS17, CASPS20 or 
CASPS21 each resulted in a roughly equivalent reduction in apoptosis. This suggests these 
caspases are all potentially involved in the apoptosis pathway in Ae. aegypti. It is difficult to 
accurately determine the extent of involvement of specific caspases in this study since silencing 
of each of the caspases showed a similar effect on apoptosis. Previously, in a study of caspases 
AeDronc, CASPS7 and CASPS8, it was observed that silencing of AeDronc had the most change 
in caspase activity compared to other two effector caspases (Liu and Clem, 2011). However, in 
our study we could not differentiate the effect of silencing of one caspase versus another.  One 
possible reason for this may be incomplete silencing of the caspases at the protein level, which 
makes it difficult to assess the effects of gene silencing. It may also be helpful in the future to co-
silence individual caspases with AeIAP1, and to study the biochemical interactions of AeIAP1 
with these different caspases. Based on the interaction of each caspase with AeIAP1, it may be 
possible to better predict the importance of specific caspases in the apoptosis pathway in Ae. 
aegypti. 
In our study, we observed that co-silencing of caspases that share high sequence similarity 
(CASPS15 and 16, and CASPS17 and 21) did not result in a significant change in the effect on 
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apoptosis compared to silencing the caspases individually (Fig. 2.5). This suggests that although 
the proteins have high sequence similarity they do not share functional redundancy. The lack of 
difference between single and double knockdown can also result from the activation of other 
caspases during apoptosis. This result can also be explained by the fact that while knocking 
down these caspases using RNAi, there might still be some level of expression of the caspases. 
We also did not observe any significant difference when the caspases were knocked down with 
the known initiator caspase AeDronc compared to the caspases being knocked down alone (Fig. 
2.6). This might have resulted from the activation of other effector caspases by the apoptotic 
stimuli as described above.  This scenario is similar to when the co-silencing of two known 
effector caspases CASPS7 and CASPS8 did not show any additional effect on the rate of 
apoptosis ( Lui and Clem, 2011).  
In addition to using caspase activity as a measurement of apoptosis, we also attempted to use 
Annexin V staining and flow cytometry. One of the hallmarks of apoptosis is the translocation of 
phospholipid phosphatidylserine (PS) from the inner to the outer surface of the plasma 
membrane.  Annexin V is a 35-36 kDa Ca2+ dependent phospholipid-binding protein which 
possesses a high binding affinity for PS. This unique feature of Annexin V can be used to 
identify apoptotic cells when conjugated to a fluorochrome such as Phycoerythrin (PE) (Vermes 
et al., 1995). Annexin V staining has the ability to determine apoptosis at a much earlier state 
compared to other methods that are based on nuclear changes (Koopman et al., 2000; Martin et 
al.,1995). 
We were able to successfully stain Aag2 cells using this method and we saw a significant 
difference in the number of apoptotic cells before and after UV treatment (Fig. 2.9). Although we 
observed a significant number of apoptotic cells, the difference was smaller than expected. This 
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may be because Annexin V is very sensitive in detection of apoptosis and is able to determine 
apoptosis at a much earlier stage than other methods that we have being using like caspase 
activity assay. Thus, if the treated cells had been collected earlier, the difference might have been 
greater. And moreover, while performing the steps that lead to staining, we had to leave the cells 
in the 12- well plates for at least 48 hours from the time dsRNA added to staining (steps include 
dsRNA addition, UV treatment and collection of cells). This much time might be too long for 
optimal results using Annexin V with these particular cells. This might be a reason why we were 
not able to observe a dramatic effect using flow cytometry on UV or ActD-treated cells 
compared to caspase activity assay data.  Nevertheless, this study is the first to use the flow 
cytometry method for measuring the rate of apoptosis in Aag2 cells and we did observe a 
significant difference between number of apoptotic cells before and after UV treatment. 
Overall, this study serves as a good starting point to begin to understand the functions of these 
previously uncharacterized caspases and study their specific roles in the apoptosis pathway or in 
other pathways in Ae. aegypti. Like other mosquitoes studied so far, Ae. aegypti has a large 
number of caspases compared to most other insects, and we know from this and previous studies 
that all of the predicted caspases are expressed in Aag2 cells and in the organism, indicating that 
they are probably all authentic, expressed genes (i.e., not pseudogenes). This study represents the 
first attempt to study the functions of several of the Ae. aegypti caspases, namely CASPS15, 
CASPS16, CASPS17, CASPS20 and CASPS21.  Apart from being involved in apoptosis these 
caspases might also be involved in other functions such as autophagy or immune response. They 
might also function in processes like cell migration or differentiation (Accorsi et al., 2015).  We 
have shown that expression of several of the caspases can be decreased in Aag2 cells using 
RNAi, and we found that many of the caspases appear to play roles in apoptosis. Since all of the 
62 
caspases studied here except CASPS20 can be phylogenetically grouped with known Drosophila 
caspases, it is surprising to see that they play a role in apoptosis pathway in Ae. aegypti since not 
all of the Drosophila caspases play a role in apoptosis. Among the caspases characterized though, 
it is likely that some may play more important roles compared to others. For example, we 
observed that AeIAP1 preferentially inhibits CASPS7 compared to CASP8. To determine the 
extent to which these individual caspases function in apoptosis, further functional studies using 
known caspase regulators like IAPs and IAP antagonists need to be performed. 
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 TABLES 
Table 2.1: Summary of caspases in Ae. aegypti: 
Name Closest Drosophila relative Prodomain length  Known functional 
role in apoptosis? 
AeDronc Dronc Long Yes 
AeDredd Dredd Long Unknown 
CASPS7 Drice and Dcp-1 Short Yes 
CASPS8 Drice and Dcp-1 Short Yes 
CASPS15 Dream and Damm Long Unknown 
CASPS16 Dream and Damm Long Unknown 
CASPS17 Dream and Damm Short Unknown 
CASPS18 Decay Short No? 
CASPS19 Decay Short No? 
CASPS20 Unknown Short Unknown 
CASPS21 Dream and Damm Long Unknown 
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Table 2.2: List of substrates used for assay 
Substrate  Substrate for mammalian caspase Characterization  
  Ac-YVAD-AFC   1    Initiator  
Ac-VDVAD-AFC 2  Initiator  
Ac-DEVD-AFC 3, 6, 7, 8 and 10  Effector  
Ac-WEHD-AFC 1, 4 and 5  Initiator  
Ac-VEID-AFC 6  Effector  
Ac-LEHD-AFC 4, 5 and 9  Initiator  
Ac-IETD-AFC 8  Initiator  
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 FIGURES 
 
 
Figure 2.1:  Active site titration of CASPS7 and CASPS8. 
Recombinant caspases were incubated with increasing concentrations of the irreversible caspase 
inhibitor ZVAD-FMK, and caspase activity was measured over time. Because ZVAD-FMK 
binds 1:1 with active caspase and the binding is irreversible, the concentration of ZVAD-FMK 
required to bring the caspase activity to zero equals the concentration of active caspase in the 
preparation. The concentration of ZVAD-FMK required to bring caspase activity zero for 
CASPS7 was 4.49 µM and for CASPS8 was 9.34 µM. 
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Figure 2.2: Caspase inhibition assay by AeIAP1. 
Increasing concentrations of recombinant AeIAP1 were incubated with equal concentrations of 
active,recombinant CASPS7 and CASPS8, and then the ability to cleave DEVD-AFC was 
determined. At 64µM of AeIAP1, the activity of Caspase 7 was significantly lower than Caspase 
8 (calculated using t-test). The level of significance in each graph is demonstrated by the ‘*’ 
where * is p-value less than 0.05, ** is p-value less than 0.005, *** is p value less than 0.0005 
and **** is p value less than 0.00005. “NS” in graphs represents at p-value greater than 0.05 
thus the difference is not significant.  Each bar represents the average of 3 biological replicates 
(+/- SE). 
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Figure 2.3: Knockdown confirmation of individual caspases. 
Aag2 cells were left untreated (Control) or treated with dsRNAs corresponding to control GFP, 
CASPS15, CASPS16, CASPS17, CASPS20 or CASPS21. 24 hrs later, the cells were harvested 
and the levels of mRNA for each gene were determined by qRT-PCR. Relative expression value 
for each treatment was calculated using the ct values. For each of the dsRNA treatment, the 
relative expression was significantly lower than dsGFP treatment (calculated using t-test) 
confirming a successful knockdown of the genes. Each bar represents the average of 3 biological 
replicates (+/- SE). 
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Figure 2.4: Caspase activity of dsRNA-treated cells collected 12 hours post-UV or -ActD 
treatment. 
 
Aag2 cells were treated with the indicated dsRNAs, and 24 hrs later the cells were exposed to A) 
UV or B) ActD. The caspase activity of the cells was measured 12 hrs later. The caspase activity 
of caspase dsRNA treated cells were significantly lower than dsGFP treated cells (calculated 
using t- test). Each bar on the graph represents the average of 3 biological replicates (+/- SE).   
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Figure 2.5: Caspase activity after double knockdown of caspases followed by UV treatment 
or Act D treatment. 
The caspase activity of the cells was measured after silencing of individual caspases or two 
caspases at a time, and exposure of the cells to A) UV or B) Act D. Double knockdown of 
caspases did not have a significant effect (p-value greater than 0.05) denoted by “NS” in the 
graphs (calculated using t-tests) compared to caspases being knocked down individually. The 
activity of caspases knocked down individually or in pairs was however significantly lower 
dsGFP treated control (calculated using t-test) confirming the role of these genes in apoptosis. 
Each bar on the graph represents the average of 3 biological replicates (+/- SE).   
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Figure 2.6: Caspase activity after double knockdown of caspases and AeDronc followed by 
UV or Act D treatment. 
Caspase activity was measured after silencing of individual caspases or double knockdown of 
caspases with the initiator caspase AeDronc and exposure to A) UV or B) Act D). Double 
knockdown of caspases did not have a significant effect (p-value greater than 0.05) compared to 
caspases being knocked down individually, which is represented by “NS” in the graphs. The 
significance was determined using t-test where “NS” represents p-value greater than 0.05. Each 
bar on the graph represents the average of 3 biological replicates (+/- SE).   
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Figure 2.7: Caspase activity of supernatant and elutions after recombinant protein 
purification. 
 Recombinant caspases with His tags were expressed in E. coli and purified as described in 
Materials and Methods. The caspase activity was measured by using DEVD-AFC as a substrate. 
For all the caspases, the supernatant had significantly higher caspase activity compared to the 
elutions, indicating that purification was not successful. The above graphs are one replicate 
representative of multiple purification attempts. 
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Figure 2.8: Substrate preference assays using clarified lysates containing recombinant 
active caspases. 
Substrate preference for the active site mutant of CASPS7 (negative control) and other caspases 
were determined using recombinant caspases. Same letters on the graph represents groups that do 
not have significant difference (determined by comparing p-values where p < 0.05 is significant) 
whereas different letters represent significant difference in the activity. The level of significance 
for each substrate was calculated using one-way ANOVA.  Each graph represents the average of 
2 biological replicates (+/- SE). 
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Figure 2.9: Raw data of flow cytomtery analysis on Aag2 cells stained with Annexin V 
and/or 7AAD. 
Aag2 cells were stained with Annexin V and/or 7AAD with or without UV treatment. The X axis 
in each graph represents the staining with Annexin V, whereas the Y axis represents staining 
with 7AAD. A) Control cells and B) UV-treated cells stained with Annexin V; C) control cells 
and D) UV-treated cells stained with 7AAD; E) control cells and F) UV-treated cells stained 
with Annexin V and 7AAD. The percentage of cells is each quadrant is represented in the boxes. 
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Figure 2.10: Mean percentages of cells stained by Annexin and 7AAD with or without UV 
treatment. 
The mean percentages of untreated and UV-treated Aag2 cells that were stained with Annexin V 
and/or 7AAD were determined by flow cytometry. The samples labeled “Control” were not 
stained with either reagent. Higher percentages of cells were stained in Annexin V and 
Annexin+7AAD treatment after UV compared to control cells. The level of significance was 
determined using t-test. Each graph represents the average of 3 biological replicates (+/- SE). 
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Figure 2.11: Mean percentage of cells stained by Annexin and/or 7AAD in caspase-knocked 
down cells with or without UV treatment. 
The mean percentage of cells stained by Annexin V and/or 7AAD was calculated in each 
treatment after caspase knockdown. UV-treated cells had significantly higher percentage of 
stained compared to on UV treatment. Each bar represents 3 biological replicates. Panel B 
represents the comparison of percentage of Annexin stained cells with and without UV 
treatment. It was observed that knockdown of CASP21 had more Annexin stained cells after UV 
treatment compared to other caspase dsRNA treatment. 
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Chapter 3 - Conclusions 
Apoptosis is known to be an important antiviral mechanism in mammals as well as insects.  
When cells are infected with viruses, they often will try to kill themselves to inhibit the growth 
and propagation of the virus to other neighboring cells (Clarke and Clem, 2003, Clem and Miller, 
1993, Scallan et al., 1997).  Diseases that are caused by viruses carried by arthropod hosts 
(arboviruses) include dengue, yellow fever, and chikungunya fever. These diseases have huge 
public health concern and are known to cause significant mortality and morbidity in the affected 
regions (WHO 2007, 2008).  Aedes aegypti, which is the subject of this study, is a vector for 
dengue, chikungunya, and yellow fever. Thus, the study of apoptosis in Ae. aegypti will help us 
better understand the mechanism of transmission of various arboviruses from insect vectors to 
the hosts. This knowledge can be used to develop future strategies to stop the transmission and 
replication of viruses in the mosquitoes. With improved knowledge of specific regulators of 
apoptosis in Ae. aegypti like caspases, we can better understand the apoptosis pathway in 
mosquitoes and use the knowledge to target specific areas of the pathway.  
The caspases included in this study, CASPS15, CASPS16, CASPS17, CASPS20 and CASPS21, 
were shown to play a role in apoptosis in Ae. aegypti. Besides being involved in apoptosis, these 
caspases may be involved in other biological processes like immune response. For example, the 
Drosophila caspase AeDredd is known to be involved in NF-kB activation. Since there are more 
caspases identified in Ae. aegypti (11) compared to Drosophila (7), it is likely that these Ae. 
aegypti caspases serve other functions along with their apoptotic function.   
 The specific roles of the caspases included in this study can be further studied by studying their 
interactions with other known regulators of apoptosis in Ae. aegypti. The genetic interaction of 
these caspases with IAP1 can be studied using RNAi. Recombinant caspases, IAPs and IAP 
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antagonists can be produced and their direct interaction can be studied using binding assays. 
These assays will help us understand the regulators that interact with specific caspases during 
apoptosis in Ae. aegypti. Mutant forms of CASPS15, 16, 17, 20 and 21 with alterations to the 
specific domains of caspase structure can also be used to study in detail the contribution of 
specific regions of the caspases in apoptosis. Studying the predicted 3D structure of these 
caspases using X-ray crystallography will also help greatly in understanding their specific 
apoptotic and non-apoptotic functions.  Apoptosis is a complex phenomenon that involves 
multiple regulators, and so further knowledge regarding the caspases discussed in this study will 
be beneficial in understanding apoptosis in mosquitoes and other insects.  
 
 
 
 
